检索结果 - Sherry Wang‐Weigand
- Showing 1 - 4 results of 4
-
1
-
2
-
3
-
4
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis 由 Matthew R. Henn, Edward J. O’Brien, Liyang Diao, Brian G. Feagan, William J. Sandborn, Curtis Huttenhower, Jennifer R. Wortman, Barbara McGovern, Sherry Wang‐Weigand, David I. Lichter, Meghan Chafee, Christopher B. Ford, Patricia Bernardo, Peng Zhao, Sheri L. Simmons, Amelia D. Tomlinson, David N. Cook, Roger J. Pomerantz, Bharat Misra, John Auniņš, Michele Trucksis
出版 2020Artigo
相关主题
Medicine
Internal medicine
Anesthesia
Insomnia
Psychiatry
Sleep disorder
Adverse effect
Alternative medicine
Apnea
Bioinformatics
Biology
Chemistry
Chronic insomnia
Circadian rhythm
Colitis
Discontinuation
Disease
Gastroenterology
Microbiology
Microbiome
Morning
Organic chemistry
Pathology
Phase (matter)
Placebo
Polysomnography
Primary Insomnia
Psychology
Sleep onset
Sleep onset latency